[작성자:] Ashley Zhu

3billion, an AI-based rare disease genetic diagnosis startup, aims for the global market by IPO. 3billion has selected Korea Investment & Securities Co. as its representative organizer and is pushing for listing on KOSDAQ, a stock market, and the Korea Exchange trading board. Until now, 3billion has been targeting the global market by advancing AI…

3billion recently held symposiums to accelerate the diagnosis of rare diseases in Malaysia. 3billion is a Korean biotechnology company that provides genetic testing services for diagnosing rare diseases. The tour’s purpose was to go beyond being a simple service provider and interacting more closely with our collaborators, whose purpose is the diagnosis of rare diseases.…

From Dec. 13-16, 3billion met many clients locally in Morocco. We presented to eight professors and students from various departments at University Hassan2 Hospital and discussed future research projects. We discussed the introduction of Gebra, a software service, with local distributor AskYourOmics. We promised to collaborate with the Moroccan Society of Pediatric Endocrinology. We will also create great opportunities…

In an interview with Seoul Economic Daily, Changwon Keum, CEO of the genetic analysis technology startup 3billion said, “As AI can increase the efficiency of identifying rare diseases necessary for doctors’ final diagnoses, the demand for AI genetic diagnosis will increase.” Traditionally, it takes 20 to 40 hours for a doctor to interpret genetic variations…

In the 6th CAGI(Critical Assessment of Genome Interpretation) Challenges, a global artificial intelligence genomic interpretation contest, 3billion took first place by predicting the rare diseases of 79 patients within the data of The Hospital for Sick Children in Canada. 3billion’s AI model recorded 58%, showing a 16%p gap from the 2nd group with a score of 42%,…

3billion released a company video explaining why rare disease is so difficult to diagnose and how 3billion is solving them. Check out the video and learn about 3billion and its solutions.

3billion has announced Dr. Hane Lee, a former UCLA professor of pathology/diagnostic medicine and human genetics, as ‘Chief Clinical Geneticist and Director of Clinical Genetic Laboratory’ overseeing the R&D for genetic diagnosis process to advance the interpretation of genetic mutation in rare diseases. Dr. Lee had been a professor at UCLA since 2011. Dr. Lee…